Shilpa Keerthivasan to Neoplasms
This is a "connection" page, showing publications Shilpa Keerthivasan has written about Neoplasms.
Connection Strength
0.204
-
CD8+ TÂ cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. Cell Rep Med. 2023 01 17; 4(1):100878.
Score: 0.077
-
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2020 05; 26(5):693-698.
Score: 0.064
-
Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020 03; 579(7798):274-278.
Score: 0.063